Anjali Kulkarni
Papers
2
Total Citations
114
H-Index
2
About
Dr. Anjali Kulkarni is a pioneering figure in interventional oncology, whose work has fundamentally advanced the precision of minimally invasive liver cancer treatments. Her research centers on the intersection of robotics and thermal ablation, specifically developing and validating robotic-assisted techniques for treating primary and secondary liver tumours. Dr. Kulkarni’s major contributions are documented in her most cited works, including a landmark 2014 study on robotic-assisted thermal ablation (63 citations) and a foundational 2013 paper detailing early clinical experience with robot-assisted radiofrequency ablation (51 citations). These studies demonstrated that CT-compatible robots could significantly enhance needle placement accuracy, thereby improving therapeutic outcomes while simultaneously reducing radiation exposure for both patients and clinical staff. Her early findings provided critical proof-of-concept, showing that robotic systems could overcome the limitations of manual ablation, particularly for complex or poorly accessible tumours. By establishing the safety and efficacy of this approach, Dr. Kulkarni’s research has laid the groundwork for the broader adoption of robotic platforms in interventional oncology, directly influencing how liver tumours are treated today and inspiring a new generation of precision-guided cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1Robotic-assisted thermal ablation of liver tumours63 citations · 2014
- 2